Exact Sciences to combine with Genomic Health in cash and stock deal valued at $2.8 billionMarket Watch • 07/29/19
Earnings Preview: Exact Sciences (EXAS) Q2 Earnings Expected to DeclineZacks Investment Research • 07/23/19
Exact Sciences Corporation (EXAS) CEO Kevin Conroy on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/01/19
Earnings Preview: Exact Sciences (EXAS) Q1 Earnings Expected to DeclineZacks Investment Research • 04/23/19
Exact Sciences Is Near an All-Time High: Here's Why It Could Go Even HigherThe Motley Fool • 04/22/19
These six stocks have 'upside' potential due to recent developments, Wall Street analysts sayCNBC • 04/18/19